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Starting from the readily available meso-1,1-methyl-
enebis(8-oxabicyclo[3.2.1]oct-6-en-3-one) (1), meso-1,1-meth-
ylenebis[(4R,4S,6R,6S)-4,6-dioxycyclohept-1-en-1-yl]tetrasil-
yl ethers 7 and 8 were obtained and transformed into all-syn
1,3,5,11,13,15-hexahydroxypentadeca-7,9-dione derivatives 9
and 10. The conversion of these intermediates into spiro-
ketals was not successful. An alternative strategy based on the
sequential and stereoselective functionalization of 1 afforded
Introduction
Spiroketals and in particular their 6,6-congeners are key
structural elements of a variety of natural products of bio-
logical interest, for example, marine macrolides, ionophores
and polyether antibiotics.[1] The spiroketal fragments are
often very important for the biological activity of the com-
pounds containing them. In particular, spongistatins (al-
tohyrtins), which were isolated from marine sponges of the
genus Spongia by three research groups in 1993,[2] display
two highly oxygenated 6,6-spiroketals in their macrolactone
skeleton (Figure 1). These marine macrolides are potent
cancer cell growth inhibitors and thus appear to represent
promising leads for the development of new anti-cancer
agents.[3] Nevertheless, their use in clinical evaluation is lim-
ited by their low natural abundance, which has stimulated
organic chemists to develop efficient synthetic routes to ad-
dress this supply issue.[4]
In addition to seminal reports by the groups of Evans,[5]
Kishi,[6] Paterson,[7] Smith,[8] Crimmins,[9] Heathcock[10]
and Ley[11] on the total syntheses of spongistatins 1 and
2, much effort has been devoted to the implementation of
straightforward and high-yielding pathways towards the
ABCD “northern” hemisphere[12] and the EF tetrahydropy-
ran subunits.[13] Our group has been involved for several
years in the development of innovative and non-iterative
strategies towards the stereocontrolled synthesis of C15 po-
lyketides and their analogues.[14] Following the recent re-
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a 1-(2,4,6,8-tetrahydroxyoctyl)cyclohept-1-ene-4,6-diol de-
rivative [(+)-15, 94% ee]. Ozonolysis of the cycloheptene
moiety of (+)-19 provided the equatorial/axial spiroketal (+)-
21. Pivaloylation of its primary alcohol moiety and Meerwein
methylation of the remaining secondary alcohol unit fur-
nished (–)-24, a potential precursor of the ketal isomer of the
CD fragment found in spongistatins 1 and 2.
Figure 1. Representative members of the spongistatin (altohyrtins)
family.
ports on the synthesis of the polyol subunit of the polyene
macrolide antibiotic RK-397[15] and on an advanced pre-
cursor of the AB spiroketal of spongistatins,[12j] we report
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herein the application of this methodology to the prepara-
tion of potential intermediates of the CD spiroketal frag-
ment.
Results and Discussion
The strategies envisaged for the synthesis of the CD spi-
roketal A (Scheme 1) involve the obtention of the keto po-
lyol precursor B either from diketone C by desymmetri-
zation (path A) or from functionalized cycloheptene D by
oxidative cleavage of the olefin and selective reduction of
the resulting aldehyde (path B). Intermediate C should arise
from the simultaneous functionalization of the diolefin
meso-E, whereas cycloheptene D should result from the
stereoselective transformation of the meso-E, which can be
produced from the readily accessible diketone 1.[14c]
Diketone 1 was converted into the exo-diacetate 2 as pre-
viously reported.[14d] For the approach by path A, silyl
ethers were envisaged as protecting moieties on the C15 skel-
eton. Boron trichloride mediated opening of the oxa bridges
followed by treatment with silyl triflates afforded chlori-
nated cycloheptenes 3 and 4 in 79 and 76% yields, respec-
tively (Scheme 2). A sequence of reductive dechlorination
followed by replacement of the acetyl groups by tert-butyl-
dimethyl or triethylsilyl moieties delivered fully protected
tetrols 7 and 8, respectively.
Diketone intermediates of type C were prepared by oxi-
dative cleavage of both olefins followed by selective re-
duction of the aldehyde moieties in situ (Scheme 3). All our
attempts at the dihydroxylation (KMnO4 or OsO4 cat./
NMO) of dienes 7 and 8 led to decomposition of the start-
ing diolefins. Ozonolysis at –78 °C followed by reductive
treatment with dimethyl sulfide afforded intermediate dial-
dehydes, which were further reduced in situ to the corre-
sponding 1,3-diketones 9 and 10. Treatment with several
hydrides such as NaBH(OAc)3, NaBH4, DIBAL-H or BH3
was not successful, either giving back the starting material
or leading to unselective reduction of both the aldehyde and
Scheme 1. Retrosynthetic scheme for the CD spiroketal of spongistatins.
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Scheme 2. Synthesis of the cycloheptene precursors (R = TES,
TBS).
ketone functionalities or inducing decomposition of the
starting materials. The use of K-selectride afforded the ex-
pected 1,3-diketone 9 in low yields. Gratifyingly, the reduc-
ing agent resulting from a mixture of BH3 and 1-amino-
ethanol provided an efficient and selective reduction of the
aldehyde moieties to deliver the 1,3-diketones 9 and 10 in
72 and 75% yields, respectively (two steps). Unfortunately,
all our attempts to desymmetrize the 1,3-diketones 9 and
10 by enantioselective reduction of one oxo group[16] failed
to produce the expected β-hydroxy ketone in reasonable
yields. Typically, by using the Corey–Bakshi–Shibata (CBS)
methodology,[17] a low conversion (63 % yield of recovered
starting material) led to a mixture of the diastereoisomeric
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alcohols 11 and 12 in yields of 10% along with diol 13 (26%
yield). Variation of the solvent, the nature of the borane
and the amount of hydride did not give satisfying results.
The low yields did not allow conclusive measurement of the
asymmetric induction by the Mosher ester methodology.[18]
As an alternative, reduction of the double bond in the keto
enols 9 and 10 was attempted, but the olefin could not be
hydrogenated. As the desymmetrization of the linear di-
ketones 9 and 10 was not successful, another approach
based on the early-stage desymmetrization of cycloheptene
derivatives of type meso-E (Scheme 1) was developed.
Scheme 3. Exploration of path A.
Following path B (Scheme 1) and our previous report,[16]
diolefin meso-2 was converted into the semi-protected hexol
(+)-15 (Scheme 4). The key reaction of this sequence was
the Sharpless asymmetric dihydroxylation reaction for the
desymmetrization of meso-E to give intermediate diol (–)-
14 with 94% ee. Etherification of the remaining secondary
alcohol of (+)-15 in the presence of PMBCl and sodium
hydride led to an inseparable 1:1 mixture of the expected
derivative and the product of migration of the p-meth-
oxybenzoyl from the C-1 to the C-6 position of the cyclo-
heptene. Other sources of the p-methoxybenzoyl group such
as p-methoxybenzyl trichloroacetimidate (PMBTCA) in the
presence of Ph3CBF4 did not prevent the migration of the
ester moiety. Finally, the alcohol at the C-6 position was
eventually protected as a tert-butyldimethylsilyl ether in
high yield (95%). Discrimination between the two p-meth-
oxybenzoyl moieties was achieved by alcoholysis in the
presence of potassium isopropoxide generated in situ, which
afforded alcohol (–)-17 in 83 % yield based on recovered
starting material (50% yield). Careful monitoring of the re-
action allowed the reaction to be stopped as soon as the
diol (–)-18 appeared. This was isolated in 5% yield and
could easily be converted back into the starting material
(+)-16 by esterification. Although treatment of (–)-17 with
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10 % of PPTS resulted in a very slow removal of the acet-
onide moiety, the use of a catalytic amount of p-TsOH in
dichloromethane provided a rapid access to diol (+)-19 in
73% yield and established the functionalities for the spiro-
cyclization step.
Scheme 4. Stereoselective functionalization following path B.
Opening of the second cycloheptene was achieved by
ozonolysis followed by reductive treatment of the interme-
diate ozonide first with dimethyl sulfide and then with K-
Selectride to provide the intermediate hemiketal 20 as a
mixture of two diastereoisomers (Scheme 5). The latter was
not isolated but submitted directly to acidic treatment. The
use of camphorsulfonic acid led to decomposition of the
starting hemiketal. Milder acids such as acetic acid failed
to induce spirocyclization. In the presence of trifluoroacetic
acid, partial removal of the primary tert-butyldimethylsilyl
ether resulted in only 23% yield of the expected spiroketal
(+)-21. By tuning the strength of the acid, optimal condi-
tions were achieved with dichloroacetic acid, which af-
forded (+)-21 in 50% yield from triol (+)-19 (three steps).
The structure of the spiroketal was assigned on the basis
of its 2D NOESY 1H NMR spectrum. The 3JH,H coupling
constants observed for protons 2-H, 3-H, 4-H, 8-H, 9-
H and 10-H as well as diagnostic NOEs (2-H/4-H) estab-
lished the chair conformation of the two rings with the tert-
butyldimethylsilyl ether at C-10 being in the axial position.
Cross-peaks between the signals of 5-H and 11-H proved
the axial orientation of the O-7 atom, whereas NOEs be-
tween 5-H/8-H established the equatorial position of O-
1. The configuration of spiroketal (+)-21 was thus assigned
as equatorial/axial whereas the natural target presents an
axial/equatorial configuration of the CD spiroketal. Appar-
ently, the silyl ether moiety at C-10 prevents the hydrogen
bridge necessary for the stabilization of the naturally occur-
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ring configuration, as depicted in the expected analogue 22,
which does not contain the silyl ether moiety.[4] The final
functionalizations involved the selective protection of the
primary alcohol as a pivaloate ester and methylation of the
alcohol at C-4 in the presence of the Meerwein salt to af-
ford (–)-24 (66 % yield) as a potential highly advanced pre-
cursor of the CD spiroketal of spongistatins.
Scheme 5. Spiroketalization and final functionalizations.
Conclusions
We have described the synthesis of an advanced precur-
sor of the CD spiroketal of spongistatins 1 and 2 in 3%
overall yield from the previously reported meso diketone 1
in 21 steps requiring the isolation of only 12 intermediates.
A sequence of highly stereoselective transformations al-
lowed the installation of the functionalities of the natural
target on the starting bicyclic template. The presence of a
protecting group at C-10 prevented the direct formation of
the natural axial/equatorial configuration at the spiro centre
and the thermodynamically favoured axial/axial isomer was
never observed. Removal of the silyl ethers and equilibra-
tion in the presence of metal cations such as Mg2+,[5a]
Zn2+,[10b] Ca2+[8a] or Hg2+[11d] should promote the forma-
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tion of the natural axial/equatorial configuration. This syn-
thetic route and the previous preparation of a precursor of
the AB spiroketal illustrate the high versatility of bicyclic
templates of type E for the asymmetric synthesis of natural
polyketides and their analogues.
Experimental Section
General: All commercially available reagents and solvents (Fluka,
Aldrich, Acros) were used without further purification. For reac-
tions requiring anhydrous conditions, dry solvents were bought
(Fluka, Aldrich). Unless otherwise noted, experiments were carried
out under argon. Reactions were monitored by TLC (Merck silica
gel 60F254 plates) with detection by UV light, KMnO4 or Pancaldi
reagents [(NH4)6MoO4, Ce(SO4), H2SO4, H2O]. Purifications were
performed by flash chromatography on silica gel (Merck no. 9385
silica gel 60, 240–400 mesh).
1H NMR spectra were recorded with the Bruker ARX-400 and
DPX-400 spectrometers at 400 MHz and the Bruker AVII-800
spectrometers at 800 MHz. Chemical shifts are given in ppm rela-
tive to the residual 1H solvent signal (MeOD: δ = 3.34 ppm; CDCl3:
δ = 7.27 ppm; C6D6: δ = 7.30 ppm) as the internal reference. 1H
NMR assignments were confirmed by 2D COSY spectra. The mul-
tiplicities given reflect apparent signal patterns. 13C NMR spectra
were recorded with the same instrument as above at 101 MHz.
Chemical shifts are given in ppm relative to the residual 13C solvent
signal (MeOD: δ = 49 ppm; CDCl3: δ = 77 ppm; C6D6: δ =
128.5 ppm). 13C NMR assignments were confirmed by 2D HSQC
spectra. Coupling constants J are given in Hz for all NMR data.
IR spectra were recorded with a Perkin–Elmer Paragon 1000 FT-
IR spectrometer. Mass spectra were recorded with the following
instruments: MALDI-TOF: Axima-CFR+ spectrometer, Kratos;
ESI-Q: Finnigan SSQ 710C spectrometer, Thermoquest; ESI-
HRMS: Q-Tof Ultima spectrometer, Micromass. Elemental analy-
ses were performed at Ilse Beetz, 96301, Kronach, Germany using
an EPFL-ISIC-LCS instrument. Optical Rotations were deter-
mined at 25 °C with a Jasco P-1020 polarimeter; [α] values are given
in units of 10–1 degcm2 g–1.
Methylenebis[(1R,1S,5S,5R,6R,6S)-5-chloro-6-(triethylsilyloxy)cy-
clohept-3-ene-1,3-diyl] Diacetate (3): A 1.0  solution of BCl3 in
DCM (8.6 mL, 3 equiv.) was added dropwise to a stirred solution
of 2 (1 g, 2.9 mmol) in anhydrous DCM (28 mL) at 0 °C. After
stirring at 0 °C for 4 h, a saturated aqueous solution of NaHCO3
(230 mL) was added slowly under vigorous stirring and the aque-
ous layer was extracted with DCM (320 mL). The combined or-
ganic extracts were dried (MgSO4) and concentrated in vacuo. The
residue was taken up in anhydrous DCM (28 mL) and cooled to
–78 °C. 2,6-Lutidine (2.5 mL, 21.5 mmol 7.5 equiv.) and TESOTf
(2 mL, 8.6 mmol, 3 equiv.) were added. After stirring at –78 °C for
1 h, the mixture was poured into a saturated aqueous solution of
NaHCO3 (25 mL) and extracted with DCM (320 mL). The com-
bined organic extracts were dried (MgSO4) and concentrated in
vacuo. Purification by chromatography on silica gel (Et2O/PE, 1:9)
afforded 3 as a colourless oil (1.46 g, 79%). Rf = 0.3 (Et2O/PE,
1:9). IR (film): ν˜ = 2955, 2915, 1730, 1370, 1245, 1100, 1025, 830,
770 cm–1. 1H NMR (400 MHz, CDCl3): δ = 5.75 (d, 3JH,H =
8.3 Hz, 2 H, 4-H, 4-H), 4.60 (dddd, 3JH,H = 11.4, 3JH,H = 11.4,
3JH,H = 2.8, 3JH,H = 2.8 Hz, 2 H, 1-H, 1-H), 4.46 (dd, 3JH,H = 2.8,
3JH,H = 8.3 Hz, 2 H, 5-H, 5-H), 3.94 (dt, 3JH,H = 11.4, 3JH,H =
2.8, 3JH,H = 2.8 Hz, 2 H, 6-H, 6-H), 2.78 (m, 2 H, 2-H, 2-H), 2.76
(s, 2 H, 8-H2), 2.47 (q, 2JH,H = 11.4, 3JH,H = 11.4, 3JH,H = 11.4 Hz,
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2 H, 7-H, 7-H), 2.04 (m, 4 H, 7-H, 7-H, 2-H, 2-H), 2.03 (s, 6 H,
2 OAc), 0.96 [t, 3JH,H = 7.8 Hz, 18 H, CH3 (TES)], 0.61 [q, 3JH,H
= 7.8 Hz, 12 H, CH2 (TES)] ppm. 13C NMR (101 MHz, CDCl3):
δ = 170.1, 141.1, 125.5, 69.3, 69.1, 63.5, 51.0, 40.4, 36.5, 21.3, 6.8,
4.7 ppm. HRMS (ESI): calcd. for C31H54Cl2O6Si2Na [M + Na]+
671.2734; found 671.2724.
Methylenebis{(1R,1S,5S,5R,6R,6S)-5-chloro-6-[(tert-butyl)(di-
methyl)silyloxy]cyclohept-3-ene-1,3-diyl} Diacetate (4): A 1.0 
solution of BCl3 in DCM (5.7 mL, 5 equiv.) was added dropwise
to a stirred solution of 2 (400 mg, 1.15 mmol) in anhydrous DCM
(11 mL) at 0 °C. After stirring at 0 °C for 4 h, a saturated aqueous
solution of NaHCO3 (230 mL) was added slowly under vigorous
stirring. The aqueous layer was extracted with DCM (320 mL)
and the combined organic extracts were dried (MgSO4) and con-
centrated in vacuo. The residue was taken up in anhydrous DCM
(11 mL) and cooled to –78 °C. 2,6-Lutidine (0.9 mL, 8 mmol
7 equiv.) and TBSOTf (0.8 mL, 3.4 mmol, 3 equiv.) were added. Af-
ter stirring at –78 °C for 1 h, the mixture was poured into a satu-
rated aqueous solution of NaHCO3 (25 mL) and extracted with
DCM (3 20 mL). The combined organic extracts were dried
(MgSO4) and concentrated in vacuo. Purification by chromatog-
raphy on silica gel (Et2O/PE, 1:10) afforded 4 as a colourless oil
(569 mg, 76 %). Rf = 0.37 (Et2O/PE, 1:9). IR (film): ν˜ = 3440
(H2O), 2930, 2855, 1737, 1240, 1105, 1025, 840 cm–1. 1H NMR
(400 MHz, CDCl3): δ = 5.73 (d, 3JH,H = 8.3 Hz, 2 H, 4-H, 4-H),
4.61 (dddd, 3JH,H = 11.4, 3JH,H = 11.4, 3JH,H = 2.7, 3JH,H = 2.7 Hz,
2 H, 1-H, 1-H), 4.45 (d, 3JH,H = 2.7, 3JH,H = 8.3 Hz, 2 H, 5-H,
5-H), 3.94 (dt, 3JH,H = 11.4, 3JH,H = 2.7, 3JH,H = 2.7 Hz, 2 H, 6-
H, 6-H), 2.76 (m, 4 H, 2-H, 2-H, 8-H2), 2.45 (q, 2JH,H = 11.4,
3JH,H = 11.4, 3JH,H = 11.4 Hz, 2 H, 7-H, 7-H), 2.04 (m, 10 H, 7-
H, 7-H, 2-H, 2-H, 2 OAc), 0.89 [s, 18 H, (CH3)3CSi], 0.08 [s, 12
H, (CH3)2Si] ppm. 13C NMR (101 MHz, CDCl3): δ = 170.1, 141.0,
125.6, 69.4, 69.0, 63.3, 51.0, 40.3, 36.6, 25.7, 21.3, 18.0, –4.6,
–4.9 ppm. HRMS (ESI): calcd. for C31H54Cl2O6Si2Na [M + Na]+
671.2734; found 671.2731.
Methylenebis[(1R,1S,6R,6S)-6-(triethylsilyloxy)cyclohept-3-ene-
1,3-diyl] Diacetate (5): Bu3SnH (1.5 mL, 5.8 mmol, 3 equiv.) and
AIBN (32 mg, 0.19 mmol, 0.1 equiv.) were added to a solution of
3 in toluene (7 mL) and the mixture was warmed to 80 °C. After
stirring at 80 °C for 3 h, the mixture was concentrated in vacuo.
Purification by chromatography on silica gel (Et2O/PE, 1:9) af-
forded 5 as a colourless oil (609 mg, 57%). Rf = 0.72 (Et2O/PE,
1:9). IR (film): ν˜ = 2955, 2925, 1730, 1370, 1265, 1245, 1020,
770 cm–1. 1H NMR (400 MHz, CDCl3): δ = 5.51 (m, 2 H, 4-H, 4-
H), 4.49 (t, 3JH,H = 11.4 Hz, 2 H, 1-H, 1-H), 3.53 (t, 3JH,H =
11.4 Hz, 2 H, 6-H, 6-H), 2.69 (d, 2JH,H = 14.5 Hz, 1 H, 8-H2), 2.67
(d, 2JH,H = 14.5 Hz, 1 H, 8-H2), 2.35 (m, 2 H, 2-H, 2-H), 2.24 (m,
6 H, 5-H2, 5-H2, 7-H, 7-H), 2.07 (m, 2 H, 2-H, 2-H), 2.02 (s, 6
H, 2 OAc), 1.80 (q, 2JH,H = 11.4, 3JH,H = 11.4, 3JH,H = 11.4 Hz, 2
H, 7-H, 7-H), 0.95 [t, 3JH,H = 8.0 Hz, 18 H, CH3 (TES)], 0.60
[q, 3JH,H = 8.0 Hz, 12 H, CH2 (TES)] ppm. 13C NMR (101 MHz,
CDCl3): δ = 170.0, 136.9, 124.6, 69.3, 67.7, 49.6, 47.9, 37.6, 36.9,
21.4, 6.8, 4.7 ppm. HRMS (ESI): calcd. for C31H56O6Si2Na [M +
Na]+ 603.3513; found 603.3505.
Methylenebis{(1R,1S,6R,6S)-6-[(tert-butyl)(dimethyl)silyloxy]cy-
clohept-3-ene-1,3-diyl} Diacetate (6): Bu3SnH (0.9 mL, 3.5 mmol,
4 equiv.) and AIBN (14 mg, 0.09 mmol, 0.1 equiv.) were added to
a solution of 4 in toluene (4 mL) and the mixture was warmed to
80 °C. After stirring at 80 °C for 5 h, the mixture was concentrated
in vacuo. Purification by chromatography on silica gel (Et2O/PE,
1:13 to 1:10) afforded 6 as a colourless oil (279 mg, 55%). Rf =
0.70 (Et2O/PE, 1:9). IR (film): ν˜ = 3220, 2915, 2850, 1730, 1470,
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1265, 1180, 740 cm–1. 1H NMR (400 MHz, CDCl3): δ = 5.51 (m,
2 H, 4-H, 4-H), 4.49 (tt, 3JH,H = 11.4, 3JH,H = 2.5 Hz, 2 H, 1-H,
1-H); 3.53 (tt, 3JH,H = 10.5, 3JH,H = 3.1 Hz, 2 H, 6-H, 6H), 2.70
(d, 2JH,H = 14.2 Hz, 1 H, 8-H2), 2.64 (d, 2JH,H = 14.2 Hz, 1 H, 8-
H2), 2.37 (dd, 2JH,H = 12.3, 3JH,H = 12.3 Hz, 2 H, 2-H, 2-H), 2.26–
2.21 (m, 6 H, 5-H2, 5-H2, 7-H, 7-H), 2.05 (d, 2JH,H = 12.3 Hz, 2
H, 2-H, 2-H), 2.02 (s, 6 H, 2 OAc), 1.78 (q, 2JH,H = 11.4, 3JH,H =
11.4, 3JH,H = 11.4 Hz, 2 H, 7-H, 7-H), 0.88 [s, 18 H, (CH3)3CSi],
0.06, 0.05 [2 s, 12 H, (CH3)2Si] ppm. 13C NMR (101 MHz, CDCl3):
δ = 170.0, 136.9, 124.6, 69.3, 68.0, 49.6, 47.8, 37.5, 36.9, 25.9, 21.4,
18.1, –4.8 ppm. HRMS (ESI): calcd. for C31H57O6Si2 [M + H]+
581.3694; found 581.3688.
1,1-Methylenebis[(4R,4S,6R,6S)-4,6-bis(triethylsilyloxy)cyclo-
hept-1-ene] (7): K2CO3 (380 mg, 2.75 mmol, 4 equiv.) was added to
a solution of 5 (400 mg, 0.69 mmol) in MeOH (7 mL). After stir-
ring at 25 °C for 2 h, the mixture was poured into a saturated aque-
ous solution of NaHCO3 (30 mL) and extracted with EtOAc
(3 30 mL). The combined organic extracts were washed with
brine, dried (MgSO4) and concentrated in vacuo. The residue was
taken up in anhydrous DCM (7 mL) and cooled to –78 °C. 2,6-
Lutidine (0.15 mL, 1.27 mmol, 7.5 equiv.) and TESOTf (0.12 mL,
0.51 mmol, 3 equiv.) were added dropwise. After stirring at –78 °C
for 1 h, the mixture was poured into a saturated aqueous solution
of NaHCO3 (30 mL) and extracted with DCM (330 mL). The
combined organic extracts were dried (MgSO4) and concentrated
in vacuo. Purification by chromatography on silica gel (Et2O/PE,
1:25) afforded 7 as a colourless oil (493 mg, 91%). Rf = 0.33 (Et2O/
PE, 1:25). IR (film): ν˜ = 2950, 2875, 1455, 1240, 1060, 1005,
740 cm–1. 1H NMR (400 MHz, CDCl3): δ = 5.53 (m, 2 H, 2-H, 2-
H), 4.45 (t, 3JH,H = 10.8, 3JH,H = 10.8 Hz, 2 H, 4-H, 4-H), 3.32
(t, 3JH,H = 10.8, 3JH,H = 10.8 Hz, 2 H, 6-H, 6-H), 2.60 (s, 2 H, 8-
H2), 2.30–2.19 (m, 8 H, 3-H2, 3-H2, 5-H, 5-H, 7-H, 7-H), 2.07
(d, 2JH,H = 13.3 Hz, 2 H, 7-H, 7-H), 1.80 (q, 2JH,H = 10.8, 3JH,H
= 10.8, 3JH,H = 10.8 Hz, 2 H, 5-H, 5-H), 0.96 [t, 3JH,H = 8.0 Hz,
18 H, CH3 (TES)], 0.94 [t, 3JH,H = 8.9 Hz, 18 H, CH3 (TES)], 0.59
[q, 3JH,H = 8.0 Hz, 12 H, CH2 (TES)], 0.52 [q, 3JH,H = 8.9 Hz, 12
H, CH2 (TES)] ppm. 13C NMR (101 MHz, CDCl3): δ = 137.6,
124.6, 68.2, 67.7, 52.9, 50.8, 40.3, 37.8, 6.8, 6.4, 4.7, 4.6 ppm.
HRMS (ESI): calcd. for C39H80O4Si4Na [M + Na]+ 747.5031;
found 747.5056.
1,1-Methylenebis{(4R,4S,6R,6S)-4,6-bis[(tert-butyl)(dimethyl)silyl-
oxy]cyclohept-1-ene} (8): K2CO3 (216 mg, 1.56 mmol, 4 equiv.) was
added to a solution of 6 (227 mg, 0.39 mmol) in MeOH (4 mL).
After stirring at 25 °C for 2 h, the mixture was poured into a satu-
rated solution of NaHCO3 (10 mL) and extracted with EtOAc
(10 mL, 3 times). The combined organic extracts were washed with
brine, dried (MgSO4) and concentrated in vacuo. The residue was
taken up in anhydrous DCM (4 mL) and cooled to –78 °C. 2,6-
Lutidine (0.3 mL, 2.7 mmol, 7 equiv.) and TBSOTf (0.27 mL,
1.17 mmol, 3 equiv.) were added dropwise. After stirring at –78 °C
for 1 h, the mixture was poured into a saturated aqueous solution
of NaHCO3 (10 mL) and extracted with DCM (310 mL). The
combined organic extracts were dried (MgSO4) and concentrated
in vacuo. Purification by chromatography on silica gel (Et2O/PE,
1:50) afforded 8 as a colourless oil (204 mg, 72%). Rf = 0.37 (Et2O/
PE, 1:75). IR (film): ν˜ = 3300 (H2O), 2915, 2850, 1470, 1265, 1180,
1050, 735 cm–1. 1H NMR (400 MHz, CDCl3): δ = 5.52 (m, 2 H, 2-
H, 2-H), 3.45 (t, 3JH,H = 10.7, 3JH,H = 10.7 Hz, 2 H, 4-H, 4-H),
3.34 (t, 3JH,H = 10.7, 3JH,H = 10.7 Hz, 2 H, 6-H, 6-H), 2.59 (s, 2
H, 8-H2), 2.27–2.18 (m, 8 H, 3-H2, 3-H2, 5-H, 5-H, 7-H, 7-H),
2.05 (m, 2 H, 7-H, 7-H), 1.75 (q, 2JH,H = 10.7, 3JH,H = 10.7, 3JH,H
= 10.7 Hz, 2 H, 5-H, 5-H), 0.89 [s, 36 H, (CH3)3CSi], 0.61 [s, 24
H, (CH3)2Si] ppm. 13C NMR (101 MHz, CDCl3): δ = 137.6, 124.6,
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68.5, 68.0, 52.7, 50.7, 40.2, 37.8, 25.9, 18.3, –4.7, –4.8 ppm. HRMS
(ESI): calcd. for C39H81O4Si4 [M + H]+ 725.5212; found 725.5253.
(3S,5S,8Z,11R,13R)-1,9,15-Trihydroxy-3,5,11,13-tetrakis(triethylsil-
yloxy)pentadec-8-en-7-one (9): After degassing the solution using
O2, a stream of ozone was passed at –78 °C through a solution of
7 (25 mg, 0.035 mmol) in DCM (0.5 mL) for 1 min. A stream of
O2 was again passed through the mixture for 1 min and Me2S
(0.01 mL, 0.138 mmol, 4 equiv.) was then added dropwise. After
stirring at –78 °C for 5 min, a solution of 1-aminoethanol
(0.002 mL, 0.034 mmol, 1 equiv.) in BH3·THF (1  in THF,
0.075 mL, 2.2 equiv.) was added dropwise. After stirring at –78 °C
for 1 h, the solution was allowed to warm up to 0 °C. After an
additional hour, methanol (10 mL) was added and the solvents
were removed under reduced pressure. The residue was purified by
flash chromatography on silica gel (DCM/MeOH, 99:1) to afford
9 as a colourless oil (19 mg, 72%). Rf = 0.50 (DCM/MeOH, 98:2).
IR (film): ν˜ = 2950, 2915, 1600, 1455, 1375, 1265, 1070, 1000,
745 cm–1. 1H NMR (400 MHz, CDCl3): δ = 5.52 (s, 1 H, 8-H), 4.16
(t, 3JH,H = 5.6 Hz, 3-H, 13-H), 4.10 (t, 3JH,H = 5.2 Hz, 2 H, 5-H,
11-H), 3.82 (m, 2 H, 1-H, 15-H), 3.73 (m, 2 H, 1-H, 15-H), 2.45
(m, 4 H, 6-H2, 10-H2), 1.89 (m, 2 H, 2-H, 14-H), 1.74–1.61 (m, 6
H, 4-H2, 12-H2, 2-H, 14-H), 0.98 [t, 3JH,H = 7.7 Hz, 18 H, CH3
(TES)], 0.96 [t, 3JH,H = 7.7 Hz, 18 H, CH3 (TES)], 0.61 [m, 24 H,
CH2 (TES)] ppm. 13C NMR (101 MHz, CDCl3): δ = 191.3, 102.4,
68.9, 66.9, 60.1, 46.9, 44.5, 37.7, 6.8, 5.0 ppm. MS (ESI): m/z = 794
[M + H]+. HRMS (ESI): calcd. for C39H85O8Si4 [M + H]+
793.5322; found 793.5334.
(3S,5S,8Z,11R,13R)-1,9,15-Trihydroxy-3,5,11,13-tetrakis[(tert-but-
yl)(dimethyl)silyloxy]pentadec-8-en-7-one (10): After degassing the
solution using O2, a stream of ozone was passed at –78 °C through
a solution of 8 (25 mg, 0.035 mmol) in DCM (0.5 mL) for 1 min.
A stream of O2 was again passed through the mixture for 1 min
and Me2S (0.01 mL, 0.138 mmol, 4 equiv.) was then added drop-
wise. After stirring at –78 °C for 5 min, a solution of 1-amino-
ethanol (0.002 mL, 0.034 mmol, 1 equiv.) in BH3·THF (1  in
THF, 0.075 mL, 2.2 equiv.) was added dropwise. After stirring at
–78 °C for 1 h, the solution was allowed to warm to 0 °C. After an
additional hour, methanol (10 mL) was added and the solvents
were removed under reduced pressure. The residue was purified by
flash chromatography on silica gel (DCM/MeOH, 99:1) to afford
10 as a colourless oil (20 mg, 75%). Rf = 0.48 (DCM/MeOH, 98:2).
IR (film): ν˜ = 2930, 2855, 1715, 1600, 1462, 1360, 1250, 1070, 1005,
830, 770 cm–1. 1H NMR (400 MHz, CDCl3): δ = 5.53 (s, 1 H, 8-
H), 4.14 (t, 3JH,H = 6.4 Hz, 2 H, 3-H, 13-H), 4.07 (t, 3JH,H = 5.6 Hz,
2 H, 5-H, 11-H), 3.81 (m, 2 H, 1-H, 15-H), 3.73 (m, 2 H, 1-H, 15-
H), 2.43 (d, 2JH,H = 6.0 Hz, 4 H, 6-H2, 10-H2), 1.87 (m, 2 H, 2-H,
14-H), 1.74 (t, 3JH,H = 6.4 Hz, 4 H, 4-H2, 12-H2), 1.72–1.65 (m, 2
H, 2-H, 14-H), 0.90 [s, 18 H, (CH3)3CSi], 0.88 [s, 18 H, (CH3)3CSi],
0.10 [s, 12 H, (CH3)2Si], 0.06 [s, 6 H, (CH3)2Si], 0.04 [s, 6 H, (CH3)
2Si] ppm. 13C NMR (101 MHz, CDCl3): δ = 191.3, 102.6, 68.6,
67.0, 59.8, 46.6, 44.4, 37.8, 25.8, 17.9, 4.4, –4.6, –4.7 ppm. HRMS
(ESI): calcd. for C39H85O8Si4 [M + H]+ 793.5322; found 793.5349.
(+)-(1S,6R)-6-[(tert-Butyl)(dimethyl)silyloxy]-4-[((4R,6S)-6-{(2R)-4-
[(tert-butyl)(dimethyl)silyloxy]-2-(4-methoxybenzoyloxy)butyl}-2,2-
dimethyl-1,3-dioxan-4-yl)methyl]cyclohept-3-en-1-yl 4-Methoxy-
benzoate [(+)-16]: 2,6-Lutidine (0.5 mL, 4.11 mmol, 3 equiv.) and
TBSOTf (0.47 mL, 2.06 mmol, 1.5 equiv.) were added dropwise at
–78 °C to a solution of (+)-15 (1 g, 1.37 mmol) in DCM (14 mL).
After stirring at –78 °C for 30 min, the mixture was poured into a
saturated aqueous solution of NaHCO3 (50 mL) and extracted with
DCM (3 50 mL). The combined organic extracts were dried
(MgSO4) and concentrated in vacuo. The residue was purified by
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flash chromatography on silica gel (EtOAct/PE, 1:10 to 1:6) to af-
ford (+)-16 as a colourless oil (1.1 g, 95 %). Rf = 0.27 (EtOAc/PE,
1:8). IR (film): ν˜ = 2930, 2855, 1710, 1605, 1510, 1255, 1165, 1100,
835, 770 cm–1. 1H NMR (400 MHz, CDCl3): δ = 7.99 (d, 3JH,H =
8.9 Hz, 4 H, COC6H4OCH3), 6.92 (d, 3JH,H = 8.9 Hz, 4 H, CO-
C6H4OCH3), 5.54 (t, 3JH,H = 6.8 Hz, 1 H, 3-H), 5.35 (m, 1 H, 2-
H), 4.81 (m, 1 H, 1-H), 3.98 (m, 1 H, 6-H), 3.90 (m, 1 H, 4-H),
3.87 (s, 6 H, 2 COC6H4OCH3), 3.70 (t, 3JH,H = 6.5 Hz, 2 H, 4-
H2), 3.62 (br. t, 3JH,H = 10.2, 3JH,H = 10.2 Hz, 1 H, 6-H2), 2.47–
2.34 (m, 4 H, 5-H, 7-H, 2-H2), 2.28 (dd, 2JH,H = 14.1, 3JH,H =
7.1 Hz, 1 H, 1-H), 2.18 (d, 2JH,H = 13.9 Hz, 5-H), 2.05 (dd, 2JH,H
= 14.1, 3JH,H = 5.9 Hz, 1 H, 1-H), 2.01–1.90 (m, 4 H, 1-H, 3-
H2, 7-H), 1.82 (ddd, 2JH,H = 14.5, 3JH,H = 5.2, 3JH,H = 5.2 Hz, 1
H, 1-H), 1.64–1.55 (m, 2 H, 5-H2), 1.29 [s, 3 H, (CH3)2C(2)],
1.26 [s, 3 H, (CH3)2C(2)], 0.88 [s, 9 H, (CH3)3CSi], 0.87 [2s, 9 H,
(CH3)3CSi], 0.08 [s, 3 H, (CH3)2Si], 0.07 [s, 3 H, (CH3)2Si], 0.02 [s,
6 H, (CH3)2Si] ppm. 13C NMR (101 MHz, CDCl3): δ = 165.7,
165.4, 163.3, 137.6, 131.5, 123.0, 122.7, 113.5, 100.3, 69.8, 69.4,
67.6, 65.0, 63.9, 59.6, 55.4, 47.8, 45.9, 42.2, 40.4, 38.5, 37.4, 33.5,
25.9, 25.8, 24.8, 24.7, 18.3, 18.1, –4.7, –5.4 ppm. HRMS (ESI):
calcd. for C46H73O10Si2 [M + H]+ 841.4742; found 841.4756.
C46H72O10Si2 (841.2): C 65.68, H 8.63; found C 65.90, H 8.37.
[α]58925 = +3, [α]57725 = +7, [α]43525 = +13, [α]40525 = +17 (c = 0.15, DCM).
(–)-(2R)-4-[(tert-Butyl)(dimethyl)silyloxy]-1-[(4S,6R)-6-({(4S,6R)-6-
[(tert-butyl)(dimethyl)silyloxy]-4-hydroxycyclohept-1-en-1-
yl}methyl)-2,2-dimethyl-1,3-dioxan-4-yl]but-2-yl 4-Methoxybenzo-
ate [(–)-17] and (–)-(1S,6R)-6-[(tert-Butyl)(dimethyl)silyloxy]-4-
[ ( (4R ,6R ) -6 -{ (2R ) -4 - [ ( ter t -buty l ) (d imethy l ) s i ly loxy ] -2-
hydroxybutyl}-2,2-dimethyl-1,3-dioxan-4-yl)methyl]cyclohept-3-en-
1-ol [(–)-18]: Potassium (300 mg, 7.7 mmol, 5 equiv.) was added to
a solution of (+)-16 (1.2 g, 1.54 mmol) in 2-propanol (15 mL) at
0 °C. The reaction was carefully monitored by TLC and poured
into a saturated aqueous solution of NaHCO3 (80 mL) as traces of
diol (–)-18 [Rf = 0.3 (EtOAc/PE, 1:4)] appeared. After extraction
with DCM (380 mL) the combined organic extracts were dried
(MgSO4) and concentrated in vacuo. The residue was purified by
flash chromatography on silica gel (EtOAc/PE, 1:8 to 2:1) to afford
(+)-15 [480 mg, 39%; Rf = 0.84 (EtOAc/PE, 1:4)], the desired free
alcohol (–)-17 as a colourless oil [504 mg, 50%; Rf = 0.46 (EtOAc/
PE, 1:4)] and diol (–)-18 [41 mg, 5%; Rf = 0.3 (EtOAc/PE, 1:4)].
Data for (–)-17: IR (film): ν˜ = 2930, 2855, 1710, 1605, 1510, 1255,
1165, 1095, 835, 770 cm–1. 1H NMR (400 MHz, CDCl3): δ = 7.98
(d, 3JH,H = 8.9 Hz, 2 H, COC6H4OCH3), 6.92 (d, 3JH,H = 8.9 Hz,
2 H, COC6H4OCH3), 5.50 (t, 3JH,H = 6.7 Hz, 1 H, 2-H), 5.35
(m, 1 H, 2-H), 3.96 (m, 1 H, 4-H), 3.90 (m, 1 H, 6-H), 3.87 (s, 3
H, COC6H4OCH3), 3.73 (m, 1 H, 6-H), 3.70 (t, 3JH,H = 6.7 Hz,
2 H, 4-H2), 3.66 (m, 1 H, 4-H), 2.38 (dd, 2JH,H = 14.2, 3JH,H =
9.3 Hz, 1 H, 7-H), 2.32–2.20 (m, 4 H, 3-H2, 1-H, 7-H),
2.15 (br. d, 2JH,H = 12.9 Hz, 1 H, 5-H), 2.05 (dd, 2JH,H = 13.9,
3JH,H = 5.9 Hz, 1 H, 1-H), 1.99–1.88 (m, 4 H, 1-H, 3-H2, 5-H),
1.82 (ddd, 2JH,H = 14.2, 3JH,H = 5.1, 3JH,H = 5.1 Hz, 1 H, 1-H),
1.67–1.55 (m, 2 H, 5-H2), 1.26 [s, 3 H, (CH3)2C(2)], 1.27 [s, 3 H,
(CH3)2C(2)], 0.89 [s, 9 H, (CH3)3CSi], 0.87 [2 s, 9 H, (CH3)3CSi],
0.07 [s, 6 H, (CH3)2Si], 0.01 [s, 6 H, (CH3)2Si] ppm. 13C NMR
(101 MHz, CDCl3): δ = 165.6, 163.2, 137.1, 131.5, 123.4, 123.1,
113.5, 100.2, 69.4, 67.9, 67.6, 64.9, 63.9, 59.5, 55.4, 49.2, 46.1, 41.2,
40.4, 38.5, 37.4, 36.4, 25.9, 25.8, 24.8, 24.7, 18.2, 18.0, –4.7, –4.8,
–5.4, –5.5 ppm. HRMS (ESI): calcd. for C38H66O8Si2Na [M +
Na]+ 729.4194; found 729.4168. C38H66O8Si2 (707.1): C 64.55, H
9.41; found C 64.75, H 9.28. [α]58925 = –3, [α]57725 = +3 (c = 0.15,
DCM).
Data for (–)-18: IR (film): ν˜ = 2930, 2855, 1470, 1380, 1255, 1095,
835, 775 cm–1. 1H NMR (400 MHz, CDCl3): δ = 5.51 (t, 3JH,H =
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6.4 Hz, 1 H, 3-H), 4.05 (m, 1 H, 6-H), 3.94–3.87 (m, 2 H, 2-H,
4-H), 3.79 (m, 1 H, 4-H), 3.71 (m, 1 H, 6-H), 3.66 (m, 1 H, 1-
H), 3.66 (m, 1 H, 4-H), 2.39 (dd, 2JH,H = 14.7, 3JH,H = 9.6 Hz, 1
H, 5-H), 2.32–2.22 (m, 4 H, 2-H2, 1-H, 5-H), 2.14 (br. d, 2JH,H =
13.1 Hz, 1 H, 7-H), 2.07 (dd, 2JH,H = 14.4, 3JH,H = 6.4 Hz, 1 H,
1-H), 1.91 (m, 1 H, 7-H), 1.69–1.56 (m, 6 H, 1-H2, 3-H2, 5-
H2), 1.36 [s, 3 H, (CH3)2C(2)], 1.34 [s, 3 H, (CH3)2C(2)], 0.89 [s,
18 H, (CH3)3CSi], 0.07 [s, 6 H, (CH3)2Si], 0.06 [s, 6 H, (CH3)2-
Si] ppm. 13C NMR (101 MHz, CDCl3): δ = 136.9, 123.6, 100.4,
69.3, 67.9, 67.6, 66.7, 64.9, 61.1, 49.2, 46.2, 42.8, 41.2, 39.4, 38.4,
36.4, 25.8, 24.8, 18.2, 18.0, –4.8, –5.4 ppm. HRMS (ESI): calcd. for
C30H61O6Si2 [M + H]+ 573.4007; found 573.3983. [α]58925 = –16,
[α]57725 = –51 (c = 0.1, DCM).
(+)-(3R,5S,7R)-1-[(tert-Butyl)(dimethyl)silyloxy]-8-{(4S,6R)-6-
[(tert-butyl)(dimethyl)silyloxy]-4-hydroxycyclohept-1-en-1-yl}-5,7-di-
hydroxyoct-3-yl 4-Methoxybenzoate [(+)-19]: pTsOH (11 mg,
0.06 mmol, 0.05 equiv.) was added to a solution of (–)-17 (814 mg,
1.15 mmol) in DCM (24 mL) at 0 °C. After 8 h, the reaction was
poured into a saturated aqueous solution of NaHCO3 (50 mL) and
extracted with EtOAc (350 mL). The combined organic extracts
were washed with brine, dried (MgSO4) and concentrated in vacuo.
The residue was purified by flash chromatography on silica gel
(DCM/MeOH, 99:1 to 98:2) to afford (+)-19 as a colourless oil
(560 mg, 73%). Rf = 0.48 (DCM/MeOH, 98:2). IR (film): ν˜ = 3385,
2925, 2855, 1705, 1605, 1510, 1255, 1165, 1100, 1030, 835 cm–1.
1H NMR (400 MHz, CDCl3): δ = 7.98 (d, 3JH,H = 8.9 Hz, 2 H,
COC6H4OCH3), 6.92 (d, 3JH,H = 8.9 Hz, 2 H, COC6H4OCH3),
5.60 (t, 3JH,H = 6.8 Hz, 1 H, 2-H), 5.32 (m, 1 H, 3-H), 4.11 (m, 1
H, 5-H), 3.99 (m, 1 H, 7-H), 3.86 (s, 3 H, COC6H4OCH3), 3.84
(m, 1 H, 4-H), 3.73 (m, 3 H, 1-H2, 6-H), 3.13, 2.49 [d, 2 H,
C(OH)], 2.44–2.35 (m, 2 H, 7-H, 3-H), 2.29 (m, 2 H, 7-H, 3-H),
2.18 (br. d, 2JH,H = 6.5 Hz, 2 H, 8-H2), 2.04–1.97 (m, 5 H, 4-H, 2-
H2, 5-H2), 1.87 (dt, 2JH,H = 14.2, 3JH,H = 4.9, 3JH,H = 4.9 Hz, 1
H, 4-H), 1.66 (m, 2 H, 6-H2), 0.87 [s, 18 H, (CH3)3CSi], 0.07 [s, 3
H, (CH3)2Si], 0.06 [s, 3 H, (CH3)2Si], 0.01 [s, 6 H, (CH3)2Si] ppm.
13C NMR (101 MHz, CDCl3): δ = 166.1, 63.4, 137.7, 131.6, 125.0,
122.7, 113.6, 70.2, 68.1, 67.5, 66.7, 66.3, 59.6, 55.4, 48.5, 48.1, 42.5,
42.3, 40.7, 37.6, 36.1, 25.9, 25.7, 18.2, 17.9, –4.8, –5.0, –5.4,
–5.5 ppm. HRMS (ESI): calcd. for C35H63O8Si2 [M + H]+
667.4061; found 667.4039. C35H62O8Si2 (667.0): C 63.02, H 9.37;
found C 63.18, H 9.40. [α]58925 = +10, [α]57725 = +14, [α]43525 = +23,
[α]40525 = +30 (c = 0.2, DCM).
(+)-(2R)-4-[(tert-Butyl)(dimethyl)silyloxy]-1-{(2S,4S,6R,8S,10S)-10-
[(tert-butyl)(dimethyl)silyloxy]-4-hydroxy-8-(2-hydroxyethyl)-1,7-di-
oxaspiro[5.5]undec-2-yl}but-2-yl 4-Methoxybenzoate [(+)-21]: A
stream of ozone was passed at –78 °C through a solution of (+)-19
(120 mg, 0.18 mmol) in DCM (6 mL) for 2 min. A stream of O2
was passed through the mixture for 2 min and Me2S (0.03 mL,
0.36 mmol, 2 equiv.) was then added dropwise. After stirring at
–78 °C for 5 min the solvents were evaporated under reduced pres-
sure at –35 °C. The residue was dissolved in THF (6 mL) and co-
oled to –78 °C. At –78 °C, K-selectride (1  in THF, 0.2 mL,
0.2 mmol, 1.1 equiv.) was added dropwise. After stirring at –78 °C
for 1 h, semi-saturated NH4Cl in MeOH was added and the sol-
vents were removed in vacuo. The residue was filtered through a
pad of silica gel (DCM/MeOH, 97:3) to afford a mixture of hemi-
ketals 20. Dichloroacetic acid (1.5 µL, 0.018 mmol, 0.1 equiv.) was
added to a solution of the crude hemiketals in toluene (2.4 mL) at
0 °C. After 5 min the solution was warmed to 25 °C. After 20 min
the reaction mixture was poured into a saturated solution of
NaHCO3 (20 mL) and extracted with EtOAc (320 mL). The
combined organic extracts were washed with brine, dried (MgSO4)
and concentrated in vacuo. The residue was purified by flash
Eur. J. Org. Chem. 2010, 1895–1903 © 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.eurjoc.org 1901
chromatography on silica gel (DCM/MeOH, 98:2) to afford (+)-21
as a colourless oil [60 mg, 50%, four steps starting from the triol
(+)-19]. Rf = 0.34 (AcOEt/EP, 1:1). IR (film): ν˜ = 2955, 2930, 2855,
1710, 1605, 1255, 110, 835, 775 cm–1. 1H NMR (400 MHz, C6D6):
δ = 8.38 (d, 3JH,H = 8.9 Hz, 2 H, COC6H4OCH3), 6.86 (d, 3JH,H =
8.6 Hz, 2 H, COC6H4OCH3), 5.90 (dddd, 3JH,H = 6.4, 3JH,H = 6.4,
3JH,H = 12.0, 3JH,H = 12.0 Hz, 1 H, 2-H), 4.40 (ddd, 3JH,H = 11.1,
3JH,H = 5.5, 3JH,H = 5.5 Hz, 1 H, 2-H), 4.27 (dddd, 3JH,H = 9.6,
3JH,H = 9.6, 3JH,H = 4.0, 3JH,H = 4.0 Hz, 1 H, 8-H), 4.15 (br. t,
3JH,H = 4.0 Hz, 1 H, 10-H), 4.09 (dddd, 3JH,H = 11.1, 3JH,H =
11.1, 3JH,H = 5.5, 3JH,H = 5.5 Hz, 1 H, 4-H), 3.88 (t, 3JH,H =
6.4 Hz, 2 H, 4-H2), 3.79 (m, 2 H, 2-H2), 3.30 (s, 3 H, CO-
C6H4OCH3), 3.01 (dd, 2JH,H = 13.8, 3JH,H = 3.7 Hz, 1 H, 5-H),
2.29 (ddd, 3JH,H = 13.8, 3JH,H = 6.9, 3JH,H = 6.9 Hz, 1 H, 1-H),
2.17 (ddd, 2JH,H = 6.5, 3JH,H = 6.5, 3JH,H = 6.5 Hz, 2 H, 3-H2),
2.07 (br. dd, 2JH,H = 11.1 Hz, 1 H, 3-H), 1.93 (m, 1 H, 1-H), 1.90
(m, 2 H, 11-H2), 1.83, 1.65 (2 m, 2 H, 1-H2), 1.58 (ddd, 2JH,H =
9.6, 3JH,H = 9.6, 3JH,H = 4.0 Hz, 1 H, 9-H), 1.49 (m, 1 H, 9-H),
1.36 (m, 1 H, 5-H), 1.13 (m, 2JH,H = 11.1, 3JH,H = 11.1, 3JH,H =
11.1 Hz, 1 H, 3-H), 1.14 [s, 9 H, (CH3)3CSi], 1.08 [s, 9 H,
(CH3)3CSi], 0.21 [s, 3 H, (CH3)2Si], 0.19 [s, 3 H, (CH3)2Si], 0.13 [s,
3 H, (CH3)2Si], 0.12 [s, 3 H, (CH3)2Si] ppm. 13C NMR (101 MHz,
C6D6): δ = 166.3, 164.1, 132.6, 124.4, 114.4, 99.9, 69.8, 68.5, 66.9,
65.6, 64.9, 61.1, 60.3, 55.3, 44.1, 42.8, 41.9, 41.7, 39.5, 39.2, 38.3,
26.7, 26.5, 19.0, 17.8, –5.0, –5.1, –5.2, –5.6 ppm. HRMS (ESI):
calcd. for C35H62O9Si2Na [M + Na]+ 705.3830; found 705.3859.
[α]58925 = +3, [α]57725 = –22 (c = 0.12, DCM).
(–)-(2R)-4-[(tert-Butyl)(dimethyl)silyloxy]-1-{(2S,4S,6R,8S,10S)-10-
[(tert-butyl)(dimethyl)silyloxy]-8-[2-(2,2-dimethylpropanoyloxy)-
ethyl]-4-hydroxy-1,7-dioxaspiro[5.5]undec-2-yl}but-2-yl 4-Methoxy-
benzoate [(–)-23]: A solution of pivaloyl chloride (5 µL, 0.04 mmol,
1.5 equiv.) in DCM/Py (0.15 mL, 1:3) was added dropwise to a
solution of (+)-21 (16 mg, 0.023 mmol) in DCM/Py (0.15 mL, 1:3)
at 0 °C. The mixture was stirred at 0 °C for 5 h. The reaction was
poured into a saturated aqueous solution of NaHCO3 (10 mL) and
extracted with DCM (310 mL). The combined organic extracts
were dried (MgSO4) and concentrated in vacuo. The residue was
purified by flash chromatography on silica gel (AcOEt/EP, 1:4) to
afford (–)-23 as a colourless oil (13 mg, 72%), Rf = 0.38 (AcOEt/
EP, 1:4). IR (film): ν˜ = 2925, 2855, 1715, 1605, 1510, 1465, 1255,
1165, 1100, 835, 770 cm–1. 1H NMR (400 MHz, C6D6): δ = 8.37
(d, 3JH,H = 8.6 Hz, 2 H, COC6H4OCH3), 6.86 (d, 3JH,H = 8.6 Hz,
2 H, COC6H4OCH3), 5.92 (dddd, 3JH,H = 6.1, 3JH,H = 6.1, 3JH,H
= 12.3, 3JH,H = 12.3 Hz, 1 H, 2-H), 4.41 (m, 1 H, 2-H), 4.38 (m,
2 H, 2-H2), 4.23 (m, 1 H, 8-H), 4.13 (m, 1 H, 10-H), 4.03 (m, 1
H, 4-H), 3.89 (t, 3JH,H = 6.2 Hz, 2 H, 4-H2), 3.31 (s, 3 H, CO-
C6H4OCH3), 3.01 (dd, 2JH,H = 13.3, 3JH,H = 4.0 Hz, 1 H, 5-H),
2.30 (ddd, 3JH,H = 13.8, 3JH,H = 6.9, 3JH,H = 6.9 Hz, 1 H, 1-H),
2.19 (m, 2 H, 3-H2), 2.02 (br. dd, 2JH,H = 12.2 Hz, 1 H, 3-H), 1.92
(m, 1 H, 1-H), 1.89 (m, 2 H, 11-H2), 1.84 (m, 2 H, 1-H2), 1.48
(m, 2 H, 9-H2), 1.37 [s, 9 H, COC(CH3)3], 1.33 (m, 1 H, 5-H),
1.27 (m, 1 H, 3-H), 1.14 [s, 9 H, (CH3)3CSi], 1.08 [s, 9 H, (CH3)
3CSi], 0.21 [s, 3 H, (CH3)2Si], 0.19 [s, 3 H, (CH3)2Si], 0.13 [s, 3 H,
(CH3)2Si], 0.12 [s, 3 H, (CH3)2Si] ppm. 13C NMR (101 MHz,
C6D6): δ = 178.2, 166.1, 164.1, 132.5, 124.4, 114.4, 99.6, 69.8, 66.6,
65.9, 65.4, 65.0, 61.4, 60.4, 55.3, 44.1, 42.7, 42.0, 41.6, 39.4, 38.3,
36.0, 27.9, 26.6, 26.5, 23.6, 18.9, 17.4, –4.4, –4.5, –4.8 ppm. HRMS
(ESI): calcd. for C40H70O10Si2Na [M + Na]+ 789.4405; found
789.4376. [α]58925 = –5, [α]57725 = +13 (c = 0.1, DCM).
(–)-(2R)-4-[(tert-Butyl)(dimethyl)silyloxy]-1-{(2S,4S,6R,8S,10S)-10-
[(tert-butyl)(dimethyl)silyloxy]-8-[2-(2,2-dimethylpropanoyloxy)-
ethyl]-4-methoxy-1,7-dioxaspiro[5.5]undec-2-yl}but-2-yl 4-Methoxy-
benzoate [(–)-24]: Me3OBF4 (20 mg, 0.14 mmol, 9 equiv.) was
S. Favre, S. Gerber-Lemaire, P. VogelFULL PAPER
added to a solution of (–)-23 (12 mg, 0.015 mmol) and a proton
sponge (37 mg, 0.17 mmol, 11 equiv.) in DCM (0.3 mL) at 0 °C.
The mixture was stirred at 0 °C for 30 min. The reaction was
poured into a saturated aqueous solution of NaHCO3 (10 mL) and
extracted with DCM (310 mL). The combined organic extracts
were washed with citric acid (10 mL, 10% w/w), dried (MgSO4)
and concentrated in vacuo. The residue was purified by flash
chromatography on silica gel (AcOEt/EP, 1:8) to afford (–)-24 as a
colourless oil (8 mg, 66%). Rf = 0.31 (AcOEt/EP, 1:8). IR (film): ν˜
= 2955, 2925, 2885, 1730, 1715, 1605, 1510, 1460, 1255, 1165, 1095,
835 cm–1. 1H NMR (400 MHz, C6D6): δ = 8.37 (d, 3JH,H = 8.5 Hz,
2 H, COC6H4OCH3), 6.85 (d, 3JH,H = 8.5 Hz, 2 H, CO-
C6H4OCH3), 5.95 (dddd, 3JH,H = 6.2, 3JH,H = 6.2, 3JH,H = 12.0,
3JH,H = 12.0 Hz, 1 H, 2-H), 4.45 (m, 1 H, 2-H), 4.40 (t, 3JH,H =
5.5 Hz, 2 H, 2-H2), 4.24 (dddd, 3JH,H = 6.2, 3JH,H = 6.2, 3JH,H =
12.0, 3JH,H = 12.0 Hz, 1 H, 8-H), 4.12 (m, 1 H, 10-H), 3.90 (t,
3JH,H = 6.3 Hz, 2 H, 4-H2), 3.78 (m, 1 H, 4-H), 3.40 [s, 3 H, C(4)
OCH3], 3.31 (s, 3 H, COC6H4OCH3), 3.18 (dd, 2JH,H = 13.6, 3JH,H
= 3.5 Hz, 1 H, 5-H), 2.33 (m, 1 H, 3-H), 2.30 (m, 1 H, 1-H), 2.20
(ddd, 2JH,H = 6.5, 3JH,H = 6.5, 3JH,H = 6.5 Hz, 1 H, 3-H2), 1.96
(m, 1 H, 1-H), 1.89 (m, 4 H, 11-H2, 1-H2), 1.47 (m, 3 H, 5-H,
9-H2), 1.40 (m, 1 H, 3-H), 1.36 [s, 9 H, COC(CH3)3], 1.13 [s, 9
H, (CH3)3CSi], 1.07 [s, 9 H, (CH3)3CSi], 0.21 [s, 3 H, (CH3)2Si],
0.19 [s, 3 H, (CH3)2Si], 0.11 [s, 3 H, (CH3)2Si], 0.09 [s, 3 H, (CH3)2-
Si] ppm. 13C NMR (101 MHz, C6D6): δ = 178.1, 166.1, 164.1,
132.5, 124.4, 114.4, 99.6, 73.9, 69.9, 66.7, 65.9, 65.5, 61.5, 60.4,
55.5, 55.3, 44.2, 41.7, 39.8, 39.4, 38.2, 36.2, 27.8, 26.6, 26.4, 23.6,
8.9, 18.5, –4.2, –4.4, –4.6 ppm. HRMS (ESI): calcd. for C41H72O10-
Si2Na [M + Na]+ 803.4562; found 803.4549. C41H72O10Si2 (781.2):
C 63.04, H 9.29; found C 63.11, H 9.32. [α]58925 = –11, [α]57725 = –16,
[α]43525 = –29, [α]40525 = –36 (c = 0.14, DCM).
Supporting Information (see also the footnote on the first page of
this article): Experimental procedures and full analytical data (in-
cluding 1H, 13C and 2D spectra) for compounds 3–10, (+)-16, (–)-
17, (–)-18, (+)-19, (+)-21, (–)-23 and (–)-24.
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